A Comparison of End-to-End Versus Reverse End-to-Side Nerve Transfer Techniques in Treating Brachial Plexus Birth Injury-Associated Glenohumeral Dysplasia

比较端端吻合与反向端侧吻合神经移植术治疗臂丛神经产伤相关肩肱关节发育不良

阅读:1

Abstract

BACKGROUND: Glenohumeral dysplasia (GHD) commonly occurs following brachial plexus birth injuries and, if not addressed appropriately, can result in shoulder dysfunction. Despite its severity, there are no clearly defined surgical criteria for correcting GHD. This study compares the outcomes of end-to-end and reverse end-to-side spinal accessory to suprascapular nerve transfers for correction of GHD. METHODS: All patients presented with shoulder functional limitations, as indicated by Active Movement Scale (AMS) scores in shoulder abduction, shoulder flexion, and external rotation, and evidence of GHD, confirmed by alpha angle measurements obtained on point-of-care-ultrasounds. Demographics, outcome measures, and differences between cohorts were analyzed and compared. RESULTS: Seven infants underwent treatment with reverse end-to-side at a mean age of 6.0 months and 6 with end-to-end at a mean age of 10.3 months. The mean follow-up time for the reverse end-to-side cohort was 14.1 (SD 6.3) months and 15.1 (SD 5.3) months for the end-to-end cohort. At latest follow-up, both approaches demonstrated significant improvement in all outcome measures with the entirety of the reverse end-to-side cohort achieving full recovery of external rotation postoperatively (AMS 7). When comparing the 2 techniques, both groups exhibited similar functional outcomes with no significant differences noted in GHD correction between the 2 approaches. CONCLUSION: Depending on the clinical scenario, the reverse end-to-side nerve transfer offers a valuable addition to the therapeutic arsenal for correcting GHD and should be highly considered in treatment options. LEVEL OF EVIDENCE: II.

特别声明

1、本页面内容包含部分的内容是基于公开信息的合理引用;引用内容仅为补充信息,不代表本站立场。

2、若认为本页面引用内容涉及侵权,请及时与本站联系,我们将第一时间处理。

3、其他媒体/个人如需使用本页面原创内容,需注明“来源:[生知库]”并获得授权;使用引用内容的,需自行联系原作者获得许可。

4、投稿及合作请联系:info@biocloudy.com。